¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fusion point"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • jugomaxillary point
    ±¤´ë¾Õ¾Æ·¡Á¡, Çù»ó¾ÇÁ¡
  • leaking point
    »ùÁ¡, ´©ÃâÁ¡
  • leak-point pressure
    ´©ÃâÁ¡¾Ð
  • lacrimal point
    ´«¹°Á¡
  • malar point
    ±¤´ëÁ¡
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
  • motor point
    ¿îµ¿Á¡
  • McBurney¡¯s point
    ¸Æ¹ö´ÏÁ¡
  • melting point
    ³ì´ÂÁ¡
  • melting point determination apparatus
    À¶Á¡ÃøÁ¤±â
  • mental point
    Åγ¡À¶±âÁ¡
  • mesiobuccoocclusal point angle
    ¾ÈÂʺ¼Âʱ³ÇÕ¸éÁ¡°¢
  • mesiolinguoocclusal point angle
    ¾ÈÂÊÇôÂʱ³ÇÕ¸éÁ¡°¢
  • near point
    ±ÙÁ¡
  • nodal point
    ±³Á¡, °áÀýÁ¡
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • end-point nystagmus
    ±ØÀ§´«¶³¸², ±ØÀ§¾ÈÁø
  • exclamation point hair
    °¨ÅººÎÈ£ÅÐ
  • point estimation
    Á¡ÃßÁ¤¹ý
  • point source epidemic
    ´ÜÀϰ¨¿°¿øÀ¯Çà
  • far point
    ¿øÁ¡
  • focal point
    ÃÊÁ¡
  • freezing point
    ¾î´ÂÁ¡, ºùÁ¡
  • molecular check point gene
    ºÐÀڰ˹®À¯ÀüÀÚ
  • three-point gait
    »ïÁ¡º¸Çà
  • two-point gait
    µÎÁ¡º¸Çà
  • trigger point injection
    À¯¹ßÁ¡ÁÖ»ç
  • jugomaxillary point
    ±¤´ë¾Õ¾Æ·¡Á¡, Çù»ó¾ÇÁ¡
  • lacrimal point
    ´«¹°Á¡
  • leak-point pressure
    ´©ÃâÁ¡¾Ð
  • leaking point
    »ùÁ¡, ´©ÃâÁ¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • freezing point
    ¾î´ÂÁ¡(¡­ïÇ), ºù°áÁ¡(޼̿ïÇ), ÀÀ°íÁ¡(ëêͳïÇ).
  • freezing point depression
    ¾î´ÂÁ¡°­ÇÏ(¡­Ë½ù»).
  • freezing point depression
    ¾î´ÂÁ¡°­ÇÏ
  • gingival point angle
    Ä¡°æÃ·°¢(öÍ ôÓÊÇ).
  • gluteal point
    µÐ Á¡.
  • gold point
    ±ÝÀÀ°íÁ¡(ÐÝëêͳïÇ).
  • halting point
    Á¤ÁöÁ¡(ïÎò­ïÇ).
  • heat rigor point
    ¿­°æÁ÷Á¡(¡­ïÇ).
  • heat rigor point
    ¿­°æÁ÷Á¡(ÊÙËø).
  • ice point
    ºùÁ¡(Ë×Ëø).
  • iliac point
    Àå°ñÁ¡.
  • incisal point angle
    Àý´Ü¿¬Ã·°¢(ôîÓ®æÞôÓÊÇ).
  • indifferent point
    Á߸³Á¡(ñéí¡ïÇ).
  • physiological zero point
    »ý¸®Àû ¿µÁ¡ (¡­çÍïÇ).
  • point angle
    Á¡°¢(ïÇÊÇ), ÷°¢(ôÓÊÇ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • fusion of hip
    ¾ûµ¢°üÀýÀ¶ÇÕÁõ
  • fusion of knee
    ¹«¸­°üÀýÀ¶ÇÕÁõ
  • fusion of labia
    À¶ÇÕÀ½¼ø;À½¼øÀ¯ÇÕ
  • fusion of thumb
    ¾öÁö¼Õ°¡¶ô»ÀÀ¶ÇÕÁõ
  • fusion, cell
    ¼¼Æ÷À¶ÇÕ
  • fusion-free position
    À¶ÇÕÁ¦°Å¾ÈÀ§
  • fusion-frustrated position
    À¶ÇÕÁ¦°Å¾ÈÀ§
  • glenoidal fusion
    ¾î±ú°üÀýÀ¶ÇÕÁõ
  • heat of fusion
    À¶ÇÕ¿­(ë×ùêæð).
  • labial fusion
    À½¼øÀ¶ÇÕ
  • latent heat of fusion
    À¶ÇØ(ë×ú°)Àá¿­.
  • melting ; fusion
    À¶ÇØ.
  • metacarpal fusion
    ¼ÕÇ㸮»ÀÀ¶ÇÕÁõ
  • metatarsal fusion
    ¹ßÇ㸮»ÀÀ¶ÇÕÁõ
  • motor fusion
    ¿îµ¿À¶ÇÕ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • point mutation
    Á¡º¯ÀÌ(ïÃܨì¶)
  • point quenching
    Á¡¼ÒÆÎ(ïÃá¼ÎÃ)
  • point symmetry
    Á¡´ëĪ(ïÃÓßöà)
  • restriction point
    Á¦ÇÑÁ¡(ð¤ùÚïÃ)
  • R point
    (å²) Restriction point
  • thermal death point
    ¿­»çÁ¡(æðÞÝïÃ)
  • thermal inactivation point
    ¿­ºÒȰ¼ºÈ­Á¡ (æðÝÕüÀàõûùïÃ)
  • three-point attachment
    ¼¼°÷ ºÎÂø(Üõó·)
  • three-point cross
    ¼¼Á¡ ±³Â÷(Îßó©)
  • three-point landing
    ¼¼°÷ ¾É±â
  • two-point cross
    ÀÌÁ¡±³Â÷(ì£ïÇÎßó©)
  • zero point
    ¿µÁ¡(ÖÃïÇ)
  • zero-point mutation
    ¿µÁ¡(ÖÃïÇ) º¯ÀÌ(ܨì¶)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ACF accessory clinical findings; acute care facility; anterior cervical fusion; area correction factor; ...
AF abnormal frequency; acid-fast; adult female; afebrile; aflatoxin; albumin-free; albumose-free; aldeh...
FFF degree of fineness of abrasive particles; field-flow fractionation; flicker fusion frequency
FFT fast Fourier transform; flicker fusion test or threshold
FIT fluorescein isothiocyanate; fusion inferred threshold
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FFWI fusion from within
FP fusion protein
MFP membrane fusion protein
'p' per- fusion
CCP critical control point
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • jugomaxillary point
    Çù»ó¾ÇÁ¡
  • lacrimal point
    ´©Á¡
  • latent myofascial trigger point
    ÀáÀ缺 ±Ù¸· ¹ßÅëÁ¡
    ÃËÁø¿¡ ÀÇÇØ ÅëÁõÀÌ ³ªÅ¸³ª´Â °ÍÀ» Æ÷ÇÔÇÏ¿© Ȱµ¿¼º ±Ù¸· ¹ßÅëÁ¡ÀÇ ¸ðµç Ư¼ºÀ» °¡ÁöÁö¸¸ Àڹ߼ºÀÇ ÀÓ»óÀû ÅëÁõÀ̳ª Áõ»óÀÇ ¿øÀÎÀÌ µÇÁö´Â ¾Ê´Â ±Ù¸· ¹ßÅëÁ¡.
  • latent trigger point
    ÀáÀ缺 ¹ßÅëÁ¡
  • leak-point pressure
    ´©ÃâÁ¡ ¾Ð·Â
  • leaking point
    »ùÁ¡, ´©ÃâÁ¡
  • linguo-pulpo-axial point angle
    ¼³Ãø ¼öÃø ÃàÃø ÷°¢
    3°³ÀÇ ¿Íµ¿º®ÀÌ ¼­·Î ¿¬Á¢µÇ¾î ÀÌ·ç¾îÁö´Â Á¡»óÀÇ °¢À¸·Î¼­ ¿Üº®ÀÎ ¼³¸éº®°ú ³»º®ÀÎ ¼öº®, Ãøº®ÀÌ ÇÕÇØÁ®¼­ ÀÌ·ç¾îÁø °¢ÀÌ´Ù.
  • lower yield point
    ÇÏÇ׺¹Á¡
  • maximum point of opening
    ÃÖ´ë °³±¸À§
  • melting point
    ¿ëÀ¶ Á¡, ³ì´Â Á¡
  • melting point of metal
    ±Ý¼ÓÀÇ À¶Á¡
    Ä¡°ú¿¡¼­ ±Ý¼ÓÀÇ À¶Á¡Àº Áß¿äÇÏ´Ù. Ä¡°ú Àç·á Áß¿¡¼­ º¸Ã¶¹°ÀÇ Àº, ±Ý, ±¸¸® µî°ú °°Àº ±Ý¼ÓÀÇ À¶Á¡¿¡ ´ëÇÑ Ä¡°ú ÀÇ»çÀÇ ÀÎÁö´Â º¸Ã¶¹°ÀÇ º¯¼ºÀ» ¹æÁöÇÏ´Â Áß¿äÇÑ ¿äÀÎÀÌ µÈ´Ù.
  • mental point
    ÅÎ ³¡ À¶±âÁ¡, ÇÏ¾Ç Á¡
  • mesio-bucco-occlusal point angle
    ±Ù½É Çù ±³ÇÕ¸é ÷°¢
  • mesiobuccal occlusal point angle
    ±Ù½É ÇùÇÕ¸é ÷°¢
  • motor point
    ¿îµ¿ Á¡
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
fusion area The area in and about the macula retinae in which stimulation of noncorresponding retinal points nevertheless results in stereoscopic vision.
Synonym: fusion area.
(05 Mar 2000)
fusion beat A beat triggered by more than a single electrical impulse, when the wave fronts coincide to act together on a single final pathway of activity; in the electrocardiogram, the atrial or ventricular complex when either atria or ventricles are activated jointly by two simultaneous or nearly simultaneous invading impulses.
Synonym: combination beat, mixed beat, summation beat.
(05 Mar 2000)
fusion energy <chemistry, radiobiology> The binding energy of a nucleus is the minimum energy required to dissociate it into its component neutrons and protons. Neutron or proton binding energies are those required to remove a neutron or proton, respectively, from a nucleus. Electron binding energy is that required to remove an electron from an atom or a molecule.
(16 Dec 1997)
fusion-fission hybrid <radiobiology> Proposed nuclear reactor relying on both fusion and fission reactions. A central fusion chamber would produce neutrons to induce fission in a surrounding blanket of fissionable material.
The neutron source could also be used to convert other materials into additional fissile fuels (breeder hybrid). Safer than a plain fission reactor because the fission fuel relies on the fusion neutrons, and therefore cannot achieve criticality.
On the other hand, hybrids are more complex because of the fusion power core, and still generate fission's radioactive byproducts. But a fusion-fission hybrid could be more economical and have less stringent technical requirements than a pure fusion reactor.
(05 Jan 1998)
fusion gene <molecular biology> A hybrid gene created by joining portions of two different genes (to produce a new protein) or by joining a gene to a different promoter (to alter or regulate gene transcription).
(05 Jan 1998)
fusion-inferred threshold test Employment of the phenomenon of cerebral fusion of binaural sounds to substitute for conventional masking in hearing testing.
Synonym: FIT test.
(05 Mar 2000)
fusion protein <protein> Protein formed by expression of a hybrid gene made by combining two gene sequences. Typically this is accomplished by cloning a cDNA into an expression vector in frame with an existing gene, perhaps encoding for example beta galactosidase.
(18 Nov 1997)
fusion proteins, bcr-abl Translation products of a fusion mRNA derived from the breakpoint cluster region (bcr) gene and a cellular abl (c-abl) gene translocated to chromosome 22. The p210(bcr-abl) fusion protein is found in patients with chronic myelogenous leukaemia. The p190(bcr-abl) fusion protein is found in patients with acute lymphocytic leukaemia. The activation of human c-abl by chromosomal translocation is essentially the same as the activation of murine c-abl by viral translocation in abelson murine leukaemia virus.
(12 Dec 1998)
fusion proteins, gag-onc General name for the translation products of a fusion mRNA consisting of a gag gene and a viral oncogene (v-onc). These products are thought to have the ability to transform cells.
(12 Dec 1998)
fusion proteins, gag-pol Polyprotein products of a fused portion of retroviral mRNA containing the gag and pol genes. The polyprotein is synthesised only five percent of the time since pol is out of frame with gag, and is generated by ribosomal frameshifting.
(12 Dec 1998)
fusion reactor <radiobiology> Device which creates energy in a controlled manner through fusion reactions.
(09 Oct 1997)
fusion temperature The recorded temperature at which a 20-gauge metal wire will collapse under a 3-ounce load; the recorded temperature at which porcelain becomes glazed.
(05 Mar 2000)
light-ion fusion <radiobiology> Light-Ion-Beam-Driven Inertial Confinement fusion, using beams of light ions driven at implosion targets. Pulsed-power driven accelerators are relatively efficient and cost-effective, but beam-focusing is a technical hurdle for this approach.
(09 Oct 1997)
lysosome phagosome fusion <cell biology> A process that occurs after the internalisation of a primary phagosome. Fusion of the membranes leads to the release of lysosomal enzymes into the phagosome. Some species of intracellular parasite evade immune responses by interfering with this process.
(18 Nov 1997)
alveolar point The most anterior point on the maxillary alveolar process in the midline.
Synonym: alveolar point, prostheon.
Origin: G. Ntr. Of prosthios, foremost
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • firing point
    ¹ßÈ­Á¡;¿¬¼ÒÁ¡
  • fixed point
    °íÁ¤Á¡;Á¤Á¡;°æÂû°ü ÆÄÃâ¼Ò;Áö¼­
  • flash point
    ÀÎÈ­Á¡;¹ßÈ­Á¡;ÀÏÃËÁï¹ßÀÇ À§±â;Æú¹ßÁ¡
  • focal point
    ÃÊÁ¡
  • four point stance
    4Á¡ ½ºÅĽº
  • freezing point
    ºùÁ¡
  • full point
    Á¾ÁöºÎ
  • game point
    (Å״Ͻº µîÀÇ)°ÔÀÓ Æ÷ÀÎÆ®(ÇÑ °ÔÀÓÀÇ ½Â¸®¸¦ °áÁ¤ÇÏ´Â Á¡¼ö)
  • gold point
    Á¤È­ ¼ö¼ÛÁ¡
  • grade point
    (¹Ì)(¼ýÀÚ·Î ³ªÅ¸³½)¼ºÀû ÆòÁ¡
  • grade point average
    (¹Ì)¼ºÀûÀÇ Æò±ÕÁ¡
  • growing point
    »ýÀåÁ¡
  • high point
    Áß´ëÇÑ ½ÃÁ¡;ÃÖ°íÀÇ ½Ã±â
  • ice point
    ºùÁ¡
  • infection point
    º¯°îÁ¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á